This afternoon - you're invited to a Spaces discussion between our CEO Mike Winlo and Phoenix Global Investments. Come hear about our recent progress delivering and developing new treatments for mental health. #mdmaresearch

Podcast | Earlier this year, Emyria CEO Michael Winlo joined Tracey Wilkinson of the Life Sciences WA Investor Meets Innovator podcast for an insightful discussion on psychedelic-assisted therapy. Have a listen: bit.ly/EMD-Lifescienc… $EMD #mentalhealth #EMD #PTSD #innovation

$EMD | Join Emyria CEO, Dr. Michael Winlo, for a virtual presentation at The Stock Network's ASX Gems Conference on Friday 22 March from 9-11am (AEDT). To register visit: bit.ly/AMD-ASX-Gems #Emyria #EMD #mentalhealth #EMD #PTSD #MDMATherapyResearch #innovation #invest

REPLAY | Last week #Emyria CEO Dr Michael Winlo had the opportunity to share a Company Update as part of TSN’s ASX Gems Investment Conference. If you missed the livestream, here's the replay: youtu.be/ICjy2rT8WjA $EMD #EMD #mentalhealth #PTSD #innovation #healthcare #invest

$EMD | #Emyria has entered into a binding research study agreement with charity Reach Wellness to manage a pivotal observational study to evaluate the effectiveness of Emyria’s MDMA-assisted therapy (MDMA-AT) program for first responders with #PTSD. bit.ly/EMD-Reach-agre…

$EMD | #Emyria has received approval from the Therapeutic Goods Administration (TGA) for the first female Authorised Prescriber in Australia for MDMA-assisted therapy. Read today’s ASX release: investorhub.emyria.com/announcements/… #EMD #innovation #mentalhealth #biotech #PTSD #MDMAresearch

#Emyria has today announced the opening of a new clinical facility – The Empax Centre – dedicated to the delivery and development of new treatments for mental health. Read today’s ASX release: bit.ly/EMD-Empax-Cent… $EMD #EMD #Emyria #mentalhealth #PTSD #MDMAResearch #perth #WA

Interview | #Emyria CEO Michael Winlo spoke with Jonathan Jackson at Proactive Australia about the opening of The Empax Centre, Emyria's new cutting-edge facility aimed at enhancing #mentalhealth treatments. Take a look: bit.ly/EMD-Proactive-… $EMD #EMD #innovation #research #PTSD

Podcast | Emyria CEO Dr Michael Winlo appears on ASX Briefs with Andrew Musgrave to discuss how Emyria is tackling critical gaps in mental health care. Check it out: bit.ly/EMD-ASX-Briefs $EMD #EMD #Emyria #mentalhealth #healthcare #innovation #MDMATherapyResearch #PTSD

Dr. Michael Winlo, Emyria's CEO and MD, examines strategies for scaling the business to achieve substantial returns for shareholders.

Here from our CEO and MD 👇

Hear from our CEO & MD, Dr Michael Winlo, on our scale up approach.

$EMD | Emyria’s Empax Centre has been selected for a clinical trial sponsored by Transcend Therapeutics. The trial will evaluate the safety & efficacy of methylone, known for inducing nerve cell growth in areas affected by #PTSD, depression and anxiety. bit.ly/EMD-Transcend

PTSD Awareness Day | In Australia alone, an estimated 1.5 million people live with PTSD. At Emyria, we believe the future of PTSD cares will involve deeper integration of treatment with therapy and we invite you to follow our journey. $EMD #Emyria #mentalhealth #PTSD

#Emyria is pleased to announce a $499,411 grant award from the Future Health Research and Innovation (FHRI) Seed Fund in partnership with the University of Western Australia (UWA). Read the ASX release: investorhub.emyria.com/announcements/… $EMD #EMD #research #innovation #grant UWA Research

$EMD | #Emyria has today released its Quarterly report for the period ending 30 June 2024. Take a look at today’s ASX release: bit.ly/EMD-Quarterly-… #EMD #ASX #MDMATherapyResearch #innovation #biotech #mentalhealth #health

🗞AFR Story | The FDA is calling for more robust data before approving MDMA for PTSD. Today, emyria appears in a full-page feature by Michael Smith, examining this further 👉bit.ly/EMD_AFR #health #mental #MDMA #psychedlics #innovation #research

$EMD | #Emyria CEO and MD, Dr Michael Winlo, was thrilled to address participants at the Bellberry HREC Education event in Adelaide. His presentation, "MDMA: Opportunities & Challenges," explored the unique landscape of #MDMAresearch – both in Australia and in a global context.

$EMD | #Emyria has released compelling insight into the progress of its Post-Traumatic Stress Disorder (PTSD) Program, including interim clinical results for the first eight patients. Take a look: bit.ly/EMD_InterimCli… #EMD #MDMATherapyResearch #innovation #mentalhealth

#Emyria MD, Michael Winlo, will be providing a Company overview, including interim clinical results relating to the Emyria’s #PTSD treatment program during the ShareCafe "Hidden Gems" Webinar today at 12:30pm AEST. To register bit.ly/EMD-Hidden-Gem… $EMD #invest #mentalhealth